Intellia Therapeutics and SparingVision Announce Strategic Collaboration to Develop Novel Ocular Therapies Using CRISPR/Cas9 Technology
October 13, 2021 07:01 ET | Intellia Therapeutics, Inc.
Collaboration combines Intellia’s proprietary genome editing technology platform with SparingVision’s significant ophthalmology expertise Intellia will grant SparingVision exclusive rights to its...
Evelyn D’An Joins Cytovia Therapeutics as Chief Financial Officer
October 12, 2021 12:24 ET | Cytovia Therapeutics
AVENTURA, Fla., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc. (“Cytovia”), a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited iNK and CAR (Chimeric Antigen...
Nobel Prize Winner Dr. Jennifer A. Doudna to Receive Top Award from the Women in Medicine Legacy Foundation
October 12, 2021 11:10 ET | The New York Academy of Medicine
New York, NY, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Jennifer A. Doudna, PhD, who earned the 2020 Nobel Prize in Chemistry for her groundbreaking development of genome-engineering technology, is the 2021...
Intellia Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug Application for NTLA-5001, its CRISPR/Cas9-Engineered TCR-T Cell Candidate for Acute Myeloid Leukemia
September 16, 2021 07:30 ET | Intellia Therapeutics, Inc.
NTLA-5001 is Intellia’s first ex vivo candidate using its proprietary cell engineering process for the treatment of cancer to enter clinical studyNTLA-5001 targets Wilms’ Tumor 1 (WT1), an...
CRISPR Based Therapeutics Market, 2030
September 09, 2021 08:43 ET | Research and Markets
Dublin, Sept. 09, 2021 (GLOBE NEWSWIRE) -- The "CRISPR Based Therapeutics Market by Type of Therapy, Therapeutic Approach, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global...
The Worldwide High Content Screening/Imaging Industry Should Reach $2.3 Billion by 2026
September 03, 2021 06:13 ET | Research and Markets
Dublin, Sept. 03, 2021 (GLOBE NEWSWIRE) -- The "High Content Screening/Imaging: Technologies and Global Markets 2021-2026" report has been added to's offering. The global...
Asia-Pacific $6.93 Bn Gene Therapy Market to 2030
August 26, 2021 08:43 ET | Research and Markets
Dublin, Aug. 26, 2021 (GLOBE NEWSWIRE) -- The "Asia-Pacific Gene Therapy Market Research Report: Type, Vector Type, Application, End User - Industry Analysis and Demand Forecast to 2030" report has...
Global $5.57 Billion Cell Therapy Technologies Markets, 2015-2019, 2023F, 2025F, 2030F: Cell Processing; Cell Preservation, Distribution, and Handling; Process Monitoring and Quality Control
August 11, 2021 05:18 ET | Research and Markets
Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Global Market Report 2021: COVID-19 Growth and Change" report has been added to's offering.The global...
Amfora Logo.jpg
United Soybean Board Awards $1 Million to Amfora to Continue Development of High-Protein Soy
August 09, 2021 08:10 ET | Amfora Inc
SAN FRANCISCO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The United Soybean Board awarded $1 million to Amfora, Inc., a biotechnology company that is applying gene editing to sustainably feed the planet, to...
Global Oligonucleotide Synthesis Market Report 2021: Market is Poised for Explosive Growth as Gene Technology Moves into Mainstream Healthcare, Food Production and, Even, Data Storage
August 03, 2021 06:58 ET | Research and Markets
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides and including Customized...